Premenstrual Dysphoric Disorder (PMDD) is a severe form of Premenstrual Syndrome (PMS), characterized by intense emotional and physical symptoms that occur during the luteal phase of the menstrual cycle, typically the one to two weeks before menstruation.
PMDD is more debilitating than PMS and significantly affects daily life, including work, social interactions, and relationships. In extreme cases, it can lead to suicidal feelings.
This condition affects millions of individuals worldwide. Currently, PMDD is recognized as a distinct condition under the “Depressive Disorders” category in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
Core Symptoms and DSM-5 Diagnostic Criteria for PMDD
The hallmark of PMDD lies in its pronounced mood-related symptoms. The DSM-5 diagnosis requires a consistent perimenstrual pattern of at least five symptoms—physical, emotional, or behavioral—with at least one being a core affective symptom. To meet DSM-5 criteria, PMDD symptoms must occur during most menstrual cycles in the preceding year, intensify between three and four days before menstruation, and persist until up to three days after menstruation begins. Symptoms must be absent during the post-menstrual week and cause significant distress or impairment in work, school, social activities, or relationships. These include:
- Affective lability: mood swings, tearfulness, or heightened sensitivity to rejection
- Irritability or anger: often accompanied by increased interpersonal conflict.
- Depressed mood: feelings of hopelessness or self-critical thoughts, suicidal thoughts
- Anxiety or tension: a persistent sense of unease or being on edge.
Additional cognitive-affective symptoms may involve difficulty concentrating, feeling overwhelmed, or a sense of losing control. These are often accompanied by somatic and behavioral symptoms. For the PMDD diagnosis, at least one of the following symptoms must be present:
- Decreased interest in usual activities
- Difficulty concentrating
- Low energy or fatigue
- Significant changes in appetite, overeating, or specific food cravings
- Hypersomnia or insomnia
- A feeling of being overwhelmed or out of control
- Physical symptoms such as breast tenderness or swelling, joint or muscle pain, a sensation of bloating, or weight gain
Confirming Diagnosis of Premenstrual Dysphoric Disorder
PMDD is diagnosed through detailed documentation of symptoms combined with a thorough medical, psychiatric, and lifestyle history. Physical exams and laboratory tests help rule out other conditions.
For a reliable diagnosis, symptoms should be documented using prospective daily ratings over at least two symptomatic cycles. Tools such as the Daily Record of Severity of Problems, the Calendar of Premenstrual Experiences, or the Premenstrual Assessment Form are commonly utilized. While a diagnosis can be initially based on clinical history, these daily records are critical for distinguishing PMDD from the premenstrual exacerbation of other psychiatric conditions that persist throughout the menstrual cycle.
Differentiating PMDD from Milder Premenstrual Symptoms (PMS)
Many individuals experience milder premenstrual symptoms (PMS) that do not meet the threshold for PMDD. Recently, efforts have been made to differentiate these milder forms from the severe manifestations seen in PMDD. Organizations such as the American College of Obstetricians and Gynecologists (ACOG) and the World Health Organization (WHO) have provided frameworks to describe premenstrual mood changes.
They define premenstrual syndrome (PMS) as the presence of at least one physical or psychological symptom occurring in the five days prior to menstruation, for at least three consecutive cycles, with symptoms resolving within four days after menstruation begins. Like PMDD, these symptoms must cause significant impairment and be confirmed through prospective tracking.
When Does Premenstrual Dysphoric Disorder Occur?
PMDD occurs during the luteal phase, which begins after ovulation and ends when menstruation starts. The duration of this phase is generally around two weeks but may vary. Symptoms are not experienced during pregnancy as ovulation ceases, though they may return after resumption of ovulation postpartum.
Causes and Risk Factors of Premenstrual Dysphoric Disorder
The exact cause of PMDD remains unclear, but several contributing factors have been identified:
- Hormonal Sensitivity: Heightened sensitivity to hormonal fluctuations during the menstrual cycle.
- Genetics: Variations in genes affecting hormone sensitivity may increase susceptibility.
- Brain Chemistry: Low serotonin levels, influenced by hormonal changes, may play a role in mood and behavioral symptoms.
- Lifestyle and Health Factors: Smoking, alcohol use, lack of exercise, and being overweight may worsen symptoms.
- Trauma and Stress: A history of trauma or stressful life events is a significant risk factor.
Treatment Options Premenstrual Dysphoric Disorder (PMDD)
Treatment focuses on reducing symptom severity and improving quality of life. Options include:
Medications:
- Antidepressants: Typically used during the luteal phase or continuously.
- Hormonal Therapies: Birth control pills (especially those with drospirenone) or ovulation-suppressing medications.
- Pain Relievers: NSAIDs for physical symptoms like cramps and headaches.
- Diuretics: For fluid retention and bloating.
Lifestyle Changes:
- Regular exercise and a healthy diet with limited sugar, salt, caffeine, and alcohol.
- Relaxation techniques such as yoga, meditation, or relaxation therapy.
Alternative Approaches:
- Vitamin supplements like calcium and magnesium (though evidence is limited).
- Reflexology and acupuncture (require further research).
Caring for Individuals with Premenstrual Dysphoric Disorder
Support from loved ones can make a significant difference.
- Take the condition seriously and avoid dismissing symptoms.
- Be patient and understanding during symptomatic phases.
- Assist in planning activities around the menstrual cycle.
- Encourage professional medical support.
Prognosis and Complications of Premenstrual Dysphoric Disorder
PMDD affects up to 10% of people assigned female at birth who are of childbearing age and is recognized as both a hormonal and mental health condition. Ongoing research aims to better understand and address this disorder.
With proper treatment, most individuals experience relief or a significant reduction in symptoms. However, untreated PMDD may lead to severe complications such as suicidal thoughts, worsened depression, or disrupted relationships. Early diagnosis and intervention are crucial for managing the condition effectively.
CHMC offers diagnosis and treatment for Premenstrual Dysphoric Disorder (PMDD). Contact our experts:
Read more about depression:
- Treatment for Depression
- Post Partum Depression
- Major Depressive Disorder. Diagnosis and Treatment
- Dysthymia. Diagnosis and Treatment
- Catatonic Depression. Diagnosis and Treatment
- Relaxation Techniques in Therapy for Depression
- Psychotherapy for Older Adults with Depression
- From Early Understanding to Modern Diagnosis of Depression
- Antidepressants. What They Are
- Feeling Depressed? Effects of Loneliness and Social Isolation